Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

for
Cancer, Prostate Cancers, Breast Cancers, Colon Cancer,
Location: Halifax, Montreal, Toronto, Calgary, Vancouver
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT06960291

Recruiting

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

for
Neoplasms, Child, Adolescent
Location: Providence RI, New York NY, Washington D.C. DC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 1 - 39

Code: NCT05999994

Phase 2, Recruiting

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Scarborough ME, Providence RI, Hartford CT, Quebec,
Sponsor: Children's Oncology Group

Sex: Female

Age: 0 - 39

Code: NCT06513962

Phase 3, Recruiting

Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07126301

Recruiting

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

for
Metastases, Metastatic Cancer
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 12+

Code: NCT07594431

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

for
HER2-positive Advanced Solid Tumor
Location: Boston MA, Shirley NY, Lake Success NY, New York NY,
Sponsor: DualityBio Inc.

Sex: All

Age: 18+

Code: NCT05150691

Phase 1, Phase 2, Recruiting

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

for
Metastatic Cancer, Cervical Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05475171

Phase 2, Recruiting

A Study of AWT020 in Participants With Advanced Solid Tumors

for
Advanced Cancers (Solid Tumors)
Location: Fairfax VA, Plantation FL, Nashville TN
Sponsor: Anwita Biosciences

Sex: All

Age: 18+

Code: NCT07822919

Phase 1, Recruiting

HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor

for
Solid Tumors, Adult
Location: Tamarac FL, Plantation FL, Atlanta GA
Sponsor: Hutchmed

Sex: All

Age: 18+

Code: NCT07396584

Phase 1, Phase 2, Recruiting

A Study of Music Therapy for Anxiety in People With Cancer

for
Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07845422

Recruiting

Proactive Costs of Care Study

for
Financial Burden, Financial Toxicity, Financial Stress,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18+

Code: NCT07217262

Recruiting

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

for
Febrile Neutropenia, Non-myeloid Malignancy
Location: Myrtle Beach SC, Charlotte NC, Rock Hill SC
Sponsor: Coherus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04662892

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Peabody MA, Burlington MA, Commack NY, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase 2, Recruiting

Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

for
Solid Tumor, Adult
Location: Commack NY, Harrison NY, New York NY, Middletown NJ,
Sponsor: Effector Therapeutics

Sex: All

Age: 18+

Code: NCT04092673

Phase 1, Phase 2, Recruiting

EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

for
Cancer, Breast Cancer
Location: Pittsburgh PA
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Sex: Female

Age: 20 - 70+

Code: NCT07704476

Recruiting

A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Cincinnati OH
Sponsor: Jubilant Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05268666

Phase 1, Phase 2, Recruiting

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

for
Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer,
Location: Fairfax VA, Irving TX, Austin TX, San Antonio TX
Sponsor: OncoResponse, Inc.

Sex: All

Age: 18+

Code: NCT06090266

Phase 1, Phase 2, Recruiting

Rare and Atypical Diabetes Network

for
Diabetes Mellitus, Diabetes Mellitus Progression,
Location: Boston MA, Brooklyn NY, New York NY, Baltimore MD,
Sponsor: University of South Florida

Sex: All

Age: 0+

Code: NCT05544266

Recruiting

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

for
Pediatric Cancer, Adolescent and Young Adult Cancer
Location: Hartford CT
Sponsor: Connecticut Children's Medical Center

Sex: All

Age: 15 - 25

Code: NCT06982066

Recruiting

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

for
Metastatic Malignant Neoplasm in the Brain,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05222620

Phase 2, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial